Just a moment, the page is loading...

GSK-101468/168




A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy
ropinirole
101468/168
Parkinson Disease
Phase 3
Extension study 101468/248 was conducted. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies.
June 2014